METTL16-mediated inhibition of MXD4 promotes leukemia through activation of the MYC-MAX axis. Bove G, Babaei M, Bueno-Costa A, Amin S, et al. Oncogene 2025 Sep 14. doi: 10.1038/s41388-025-03563.

Read + Share

Amedeo Smart

Independent Medical Education

Bove G, Babaei M, Bueno-Costa A, Amin S, et al. METTL16-mediated inhibition of MXD4 promotes leukemia through activation of the MYC-MAX axis. Oncogene 2025 Sep 14. doi: 10.1038/s41388-025-03563.
PMID: 40946103